| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 1306 |
水溶性金纳米棒,Water-Soluble Gold Nanorods的特性 |
306 |
YFF |
2026-01-16 |
| 1307 |
PEG化球形金纳米颗粒,PEGylated Spherical Gold Nanoparticles的制备方法 |
281 |
YFF |
2026-01-16 |
| 1308 |
金银纳米梭子,Gold-Silver Nanorods的结构组成 |
194 |
YFF |
2026-01-16 |
| 1309 |
金纳米星,Gold Nanostars的光学特性 |
238 |
YFF |
2026-01-16 |
| 1310 |
Tyramide Conjugates Cy3成为生物医学研究中低丰度靶标检测的关键工具 |
219 |
hyy |
2026-01-15 |
| 1311 |
负载生长激素脂质体温敏凝胶 |
180 |
kx |
2026-01-15 |
| 1312 |
负载成骨生长肽的静电纺丝PLGA |
230 |
kx |
2026-01-15 |
| 1313 |
PLGA负载药物卡非佐米Carfilzomib |
200 |
kx |
2026-01-15 |
| 1314 |
TPP-PEG2K-NHS,三苯基膦-聚乙二醇-N-羟基琥珀酰亚胺酯,合成路线 |
257 |
axc |
2026-01-15 |
| 1315 |
乙酸-PEG-月桂/棕榈/硬脂酸酯,AA-PEG-C12/C16/C18的核心应用 |
382 |
wyh |
2026-01-14 |
| 1316 |
LA-PEG-Alk,硫辛酸-PEG-丙炔的应用场景验证 |
238 |
wyh |
2026-01-14 |
| 1317 |
AA-PEG-PCL,乙酸-PEG-聚己内酯的应用领域 |
325 |
wyh |
2026-01-14 |
| 1318 |
Acetic Acid-PEG-DF,苯甲醛-PEG-乙酸的合成与储存 |
223 |
wyh |
2026-01-14 |
| 1319 |
DSPE-PEG-SS的核心功能 |
229 |
wyh |
2026-01-14 |
| 1320 |
负载羧甲基壳聚糖的多孔聚乳酸PLGA纳米颗粒 |
283 |
kx |
2026-01-14 |
| 1321 |
负载盐酸万古霉素PLGA微球 |
140 |
kx |
2026-01-14 |
| 1322 |
负载地塞米松的PLGA微球 |
161 |
kx |
2026-01-14 |
| 1323 |
负载芒果苷的聚乳酸-羟基乙酸(PLGA)支架 |
214 |
kx |
2026-01-14 |
| 1324 |
负载金颗粒的PLGA纳米囊 |
134 |
kx |
2026-01-14 |
| 1325 |
NHS-PEG2K-CD(β),N-羟基琥珀酰亚胺酯化聚乙二醇-β-环糊精 |
269 |
axc |
2026-01-14 |
| 1326 |
NH2-PEG2K-COOH,氨基-羧基双功能化聚乙二醇,化学组成 |
266 |
axc |
2026-01-14 |
| 1327 |
mPEG2K-多巴胺,多巴胺修饰的甲氧基聚乙二醇,反应步骤 |
304 |
axc |
2026-01-14 |
| 1328 |
Sulfo-Cyanine7.5 NHS ester,磺化花青素Cy7.5 琥珀酰亚胺酯 |
158 |
HLL |
2026-01-14 |
| 1329 |
Y-shape PEG CM,Y 型聚乙二醇 乙酸 |
218 |
HLL |
2026-01-14 |
| 1330 |
Y shape PEG SCM,Y 型聚乙二醇 琥珀酰亚胺乙酸酯 |
126 |
HLL |
2026-01-14 |
| 1331 |
Y-shape PEG-CHO,Y 型聚乙二醇 丙醛 |
168 |
HLL |
2026-01-14 |
| 1332 |
Y-shape PEG-SC,Y 型聚乙二醇 琥珀酰亚胺基碳酸酯 |
248 |
HLL |
2026-01-14 |
| 1333 |
Y-shape PEG CM,Y 型聚乙二醇 乙酸 |
262 |
HLL |
2026-01-14 |
| 1334 |
ATTO 647N-COOH,823803-95-8,ATTO 647N 羧酸 |
164 |
HLL |
2026-01-14 |
| 1335 |
AF350 tyramide,Alexa Fluor 350 酪胺 |
270 |
HLL |
2026-01-14 |
| 1336 |
DBCO-PEG1000-SH,二苯并环辛炔-聚乙二醇1000-巯基 |
231 |
HLL |
2026-01-14 |
| 1337 |
PC Mal-NHS carbonate ester,1408057-91-9,聚碳酸酯 马来酰亚胺-琥珀酰亚胺碳酸酯 |
236 |
HLL |
2026-01-14 |
| 1338 |
DCL (PSMA inhibitor)(ACUPA),2-[(3-氨基-3-羧基) 丙基] |
171 |
HLL |
2026-01-14 |
| 1339 |
Cyanine3 tetrazine,花青素Cy3 四嗪 |
153 |
HLL |
2026-01-14 |
| 1340 |
AF680-NHS,Alexa Fluor 680 琥珀酰亚胺酯 |
133 |
HLL |
2026-01-14 |
| 1341 |
Sulfo DBCO NH2,磺化二苯并环辛炔 氨基 |
184 |
HLL |
2026-01-14 |
| 1342 |
BCN Tyramide,双环 [6.1.0] 壬炔 酪胺 |
211 |
HLL |
2026-01-14 |
| 1343 |
DBCO-SS-COOH,2576471-49-1,二苯并环辛炔-二硫键-羧酸 |
199 |
HLL |
2026-01-14 |
| 1344 |
Azido-mono-amide-DOTA,1227407-76-2,叠氮-单酰胺-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
200 |
HLL |
2026-01-14 |
| 1345 |
DOTA-C4-NH2,753421-63-5,1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-C4-氨基 |
113 |
HLL |
2026-01-14 |
| 1346 |
Biotin Sulfo NHS,119616-38-5,生物素 磺化琥珀酰亚胺酯 |
120 |
HLL |
2026-01-14 |
| 1347 |
DSPE PEG Galnac,二硬脂酰基磷脂酰乙醇胺 聚乙二醇 半乳糖苷酸 |
182 |
HLL |
2026-01-14 |
| 1348 |
mPEG-NH2,MW:5000,氨基修饰的甲氧基聚乙二醇的化学结构特点 |
108 |
axc |
2026-01-14 |
| 1349 |
mPEG-N3 MW:2000,叠氮化甲氧基聚乙二醇在药物递送系统的构建原理 |
156 |
axc |
2026-01-14 |
| 1350 |
mPEG2000-双磷酸,甲氧基聚乙二醇2000-双磷酸的应用优势 |
158 |
axc |
2026-01-14 |